{"date":"2026-03-16","count":29,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7888-2026-03-16-2020-2uiif0","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-03-16","time":"20:20:11","subject":"公告本公司財務主管、會計主管及內部稽核主管異動","clause":"第11款","fact_date":"2026-03-16","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-03-16 20:20，「公告本公司財務主管、會計主管及內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2026-03-16-2014-bwopfv","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-03-16","time":"20:14:33","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-03-16 20:14，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2026-03-16-1950-11b1948","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-03-16","time":"19:50:50","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-03-16 19:50，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2026-03-16-1935-7j886t","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-03-16","time":"19:35:53","subject":"公告本公司董事會通過民國114年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-03-16 19:35，「公告本公司董事會通過民國114年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-03-16-1811-bwopfv","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-03-16","time":"18:11:27","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-03-16","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-03-16 18:11，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-03-16-1808-3gm4yh","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-03-16","time":"18:08:16","subject":"本公司股票初次上市前現金增資認股繳款期間暨暫定承銷價相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-03-16 18:08，「本公司股票初次上市前現金增資認股繳款期間暨暫定承銷價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-03-16-1755-zvlmnp","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-03-16","time":"17:55:20","subject":"公告本公司董事會解除經理人競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-03-16 17:55，「公告本公司董事會解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-03-16-1750-zjjwf3","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-03-16","time":"17:50:55","subject":"公告董事會決議辦理初次上市掛牌前現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-03-16 17:50，「公告董事會決議辦理初次上市掛牌前現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-03-16-1744-1j46v82","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-03-16","time":"17:44:32","subject":"公告本公司現金股利除息基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-03-16 17:44，「公告本公司現金股利除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-03-16-1743-1swy1a3","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-03-16","time":"17:43:48","subject":"公告本公司第1次買回庫藏股(更正買回股份總金額上限)","clause":"第53款","fact_date":"2026-03-16","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-03-16 17:43，「公告本公司第1次買回庫藏股(更正買回股份總金額上限)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-03-16-1743-2356rb","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-03-16","time":"17:43:24","subject":"公告董事會通過114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-03-16 17:43，「公告董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-03-16-1734-19nez8t","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-03-16","time":"17:34:27","subject":"公告召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-03-16 17:34，「公告召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2026-03-16-1722-1wazxg9","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2026-03-16","time":"17:22:12","subject":"公告本公司訂定115年除息基準日相關事宜","clause":"第14款","fact_date":"2026-03-16","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2026-03-16 17:22，「公告本公司訂定115年除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2026-03-16-1721-143edb0","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2026-03-16","time":"17:21:57","subject":"公告本公司決定除息基準日相關事宜","clause":"第14款","fact_date":"2026-03-16","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2026-03-16 17:21，「公告本公司決定除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-03-16-1713-143edb0","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-03-16","time":"17:13:50","subject":"公告本公司決定除息基準日相關事宜","clause":"第14款","fact_date":"2026-03-16","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-03-16 17:13，「公告本公司決定除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-03-16-1711-5pdpa9","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-16","time":"17:11:52","subject":"公告本公司115年第一次現金增資延長特定人繳款期限","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-03-16 17:11，「公告本公司115年第一次現金增資延長特定人繳款期限」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-03-16-1711-mt8ywf","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-03-16","time":"17:11:12","subject":"補充說明115年3月12日代子公司HUA KUANG MEDICAL HOLDING LIMITED(華光)公告本公司董事會授權董事長簽訂股權轉讓意向書","clause":"第53款","fact_date":"2026-03-16","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-03-16 17:11，「補充說明115年3月12日代子公司HUA KUANG MEDICAL HOLDING LIMITED(華光)公告本公司董」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2026-03-16-1615-11wjw0o","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2026-03-16","time":"16:15:47","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2026-03-16 16:15，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2026-03-16-1605-5j9yh6","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2026-03-16","time":"16:05:04","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2026-03-16 16:05，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2026-03-16-1604-p67uuk","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2026-03-16","time":"16:04:33","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2026-03-16 16:04，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2026-03-16-1604-xoscjz","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2026-03-16","time":"16:04:11","subject":"公告本公司財務主管、公司治理主管及代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2026-03-16 16:04，「公告本公司財務主管、公司治理主管及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2026-03-16-1603-1609k5a","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2026-03-16","time":"16:03:44","subject":"公告本公司永續發展委員會委員異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2026-03-16 16:03，「公告本公司永續發展委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2026-03-16-1603-hurcou","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2026-03-16","time":"16:03:16","subject":"本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2026-03-16 16:03，「本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-03-16-1601-1sucf8","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-03-16","time":"16:01:12","subject":"更正本公司115年3月12日發布之重大訊息「公告本公司新任創新長」之部分內容","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-03-16 16:01，「更正本公司115年3月12日發布之重大訊息「公告本公司新任創新長」之部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-16-1511-dl8slv","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-16","time":"15:11:04","subject":"公告本公司財務主管、會計主管暨公司治理主管異動案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-16 15:11，「公告本公司財務主管、會計主管暨公司治理主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4131-2026-03-16-1428-1wxzb4f","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2026-03-16","time":"14:28:03","subject":"公告本公司董事長依董事會授權訂定員工認股權憑證轉換普通股增資基準日","clause":"第53款","fact_date":"2026-03-16","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2026-03-16 14:28，「公告本公司董事長依董事會授權訂定員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4131-2026-03-16-1427-144kreo","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2026-03-16","time":"14:27:22","subject":"公告本公司董事長依董事會授權訂定113年第一次限制員工權利新股增資基準日","clause":"第53款","fact_date":"2026-03-16","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2026-03-16 14:27，「公告本公司董事長依董事會授權訂定113年第一次限制員工權利新股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-03-16-1408-1h3ceio","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-03-16","time":"14:08:40","subject":"公告本公司董事會決議買回庫藏股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-03-16 14:08，「公告本公司董事會決議買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-03-16-1306-1llq888","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-03-16","time":"13:06:56","subject":"更正本公司114年度累積虧損達實收資本額二分之一(年度誤植更正)","clause":"第51款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-03-16 13:06，「更正本公司114年度累積虧損達實收資本額二分之一(年度誤植更正)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}